Lars Zender
Physiology · 2006–2021
A researcher in the Science corpus: 10 papers; trusts 3 researchers and is trusted by 8 researchers here, as inferred from the citation graph.
Subfields
- Physiology — 72 citations into it; #390 of 2,276 by trust here, #114 by citations
- Epidemiology — 18 citations into it
- Hepatology — 17 citations into it
Whom Lars Zender trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Lars Zender overall
- Bin Zhao
- Duojia Pan
- J. Campisi
- K. Guan
- Fa-Xing Yu
- D. Nguyen
- Adam Freund
- Jung-Soon Mo
- T. Kuilman
- Nicolás Herranz
Papers from Lars Zender's perspective
Ordered by how strongly the researchers Lars Zender trusts endorse each paper. Same corpus, a different order for every researcher.
- Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. (Cell)
- The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1 (Oncogene)
- Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication (Nature)
- Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas (Nature)
- Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints (Nature)
- Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis. (Molecules and Cells)
- Senescence-messaging secretome: SMS-ing cellular stress (Nature Reviews. Cancer)
- From signatures to models: understanding cancer using microarrays (Nature Genetics)
- The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP. (Cell)
- A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation. (Cell)
Their papers
- Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. (2006) — 1,142 citations
- A microRNA component of the p53 tumour suppressor network (2007) — 2,843 citations
- mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype (2015) — 708 citations
- NASH limits anti-tumour surveillance in immunotherapy-treated HCC (2021) — 1,066 citations
- Innate immune sensing of cytosolic chromatin fragments through cGAS promotes senescence (2017) — 1,037 citations
- T-helper-1-cell cytokines drive cancer into senescence (2013) — 683 citations
- A complex secretory program orchestrated by the inflammasome controls paracrine senescence (2013) — 2,043 citations
- Senescence surveillance of pre-malignant hepatocytes limits liver cancer development (2011) — 1,493 citations
- Senescence of activated stellate cells limits liver fibrosis (2008) — 1,898 citations
- Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas (2007) — 2,392 citations